Ampio Pharmaceuticals

AMPE48

High Value

$0.000.00%$0.00

High Value

Penny Stock

AMPE48

$0.00

0.00%$0.00

High Value

Penny Stock

Performance History

Key Stats
Open	$0.00
Prev. Close	$0.00
EPS	-10.66
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2,497.00
PE Ratio	-

	LOW	HIGH
Day Range	0.00	0.00
52 Week Range	0.00	7.47

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-10.66

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals Inc (AMPE) is a pharmaceutical company that focuses on the development of therapies for common and prevalent inflammatory conditions. The company is headquartered in Englewood, Colorado and was founded in 2010. Ampio Pharmaceuticals Inc aims to provide innovative solutions to key medical needs. The company's core product candidates include Ampion and Optina.

Ampion is a novel therapy designed to treat inflammation and restore tissue homeostasis. It has been developed to address a range of conditions, including osteoarthritis of the knee, respiratory diseases, and diabetic macular edema. Ampion has shown promising results in clinical trials and has the potential to make a significant impact on patient outcomes. Additionally, Optina is a treatment candidate for diabetic macular edema, a leading cause of blindness worldwide. The company is actively involved in research and development efforts to further refine and expand its product portfolio.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Michael A. Martino
Headquarters: Englewood
Employees: 8
Exchange: NYSE

Keep an eye on Ampio Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ampio Pharmaceuticals 's (AMPE) price per share?

The current price per share for Ampio Pharmaceuticals (AMPE) is $0. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ampio Pharmaceuticals (AMPE)?

For Ampio Pharmaceuticals (AMPE), the 52-week high is $7.47, which is 339.45K% from the current price. The 52-week low is $0, the current price is 2.1K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ampio Pharmaceuticals (AMPE) a growth stock?

Ampio Pharmaceuticals (AMPE) has shown an average price growth of 0.41% over the past three years. It has received a score of 14 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ampio Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ampio Pharmaceuticals (AMPE) stock price performance year to date (YTD)?

As of the latest data, Ampio Pharmaceuticals (AMPE) has a year-to-date price change of -99.89%. Over the last three months, the change has been -98.31%. Over the past six months, the figure is -99.86%. Looking at a longer horizon, the five-year price change stands at -100%.

help

Is Ampio Pharmaceuticals (AMPE) a profitable company?

Ampio Pharmaceuticals (AMPE) has a net income of -$8.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$9.52M. Furthermore, the EBITDA is -$9.39M.

help

What is the market capitalization of Ampio Pharmaceuticals (AMPE)?

Ampio Pharmaceuticals (AMPE) has a market capitalization of $2.5K. The average daily trading volume is 785, indicating the stock's liquidity and investor engagement.